8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2012 / Controlled clinical trial
A controlled clinical trial divided 32 postmenopausal women into control, curcumin supplementation, or moderate aerobic exercise groups for 8 weeks. Flow-mediated dilation increased significantly and to a similar degree in both the curcumin and exercise groups, while the control group showed no change. Baseline flow-mediated dilation and key dependent variables did not differ among the three groups.
Akazawa N, Choi Y, Miyaki A, et al. Nutr Res, 2012. PMID 23146777
2012 / Post hoc analysis of a randomized double-blind placebo-controlled trial
A post hoc analysis of the WHI trial evaluated 4,143 women aged 65 and older randomized to 1,000 mg of calcium carbonate plus 400 IU of vitamin D3 (n = 2,034) or placebo (n = 2,109). Over a mean follow-up of 7.8 years, incident dementia occurred in 39 treatment participants and 37 placebo participants (HR = 1.11, 95% CI = 0.71-1.74, P = .64). Incident MCI was diagnosed in 98 treatment and 108 placebo participants (HR = 0.95, 95% CI = 0.72-1.25, P = .72). There were no significant differences in incident dementia, MCI, or global and domain-specific cognitive function between groups.
Rossom RC, Espeland MA, Manson JE, et al. J Am Geriatr Soc, 2012. PMID 23176129
2012 / Double-blind randomized clinical trial
In a double-blind randomized clinical trial, 46 elderly subjects received 500 mg magnesium or placebo daily for 8 weeks. Compared with placebo, magnesium supplementation brought about statistically significant increases in sleep time (P = 0.002), sleep efficiency (P = 0.03), serum renin (P < 0.001), and melatonin (P = 0.007). It also significantly decreased Insomnia Severity Index scores (P = 0.006), sleep onset latency (P = 0.02), and serum cortisol concentrations (P = 0.008), although total sleep time did not show a significant difference (P = 0.37).
Abbasi B, Kimiagar M, Sadeghniiat K, et al. J Res Med Sci, 2012. PMID 23853635
2011 / Randomized controlled trial
Sixty postmenopausal women underwent a 1-month washout and were then randomized to regular tomato juice (30 mg lycopene/day), lycopene-rich tomato juice (70 mg/day), Lyc-O-Mato capsules (30 mg/day), or placebo capsules for 4 months. Participants receiving tomato juice or lycopene capsules were analyzed together as a lycopene-supplemented group. Compared to placebo, 4 months of lycopene supplementation significantly increased serum lycopene (p < 0.001) and total antioxidant capacity (p < 0.05). Lycopene also led to significant reductions in lipid peroxidation (p < 0.05 vs placebo change), protein oxidation (p < 0.005 vs placebo change), and the bone resorption marker NTx (p < 0.02 vs placebo change).
Mackinnon ES, Rao AV, Josse RG, et al. Osteoporos Int, 2011. PMID 20552330
2011 / Intervention study
An analysis of the first year of data from a commercial health maintenance program (PattonProtocol-1) evaluated the effects of 10-50 mg daily of the telomerase activator TA-65 along with a dietary supplement pack and physician counseling. In vivo, there were significant declines in the percent of senescent cytotoxic (CD8(+)/CD28(-)) T cells at 6, 9, and 12 months (p = 0.018, 0.0024, and 0.0062) and natural killer cells at 6 and 12 months (p = 0.028 and 0.00013), mostly in CMV-seropositive subjects. In a subset measured at baseline and 12 months, mean telomere length did not increase, but the percent of short (<4 kbp) telomeres significantly decreased (p = 0.037). No adverse events were attributed to the protocol, and controlled randomized trials are planned to assess TA-65-specific effects.
Harley CB, Liu W, Blasco M, et al. Rejuvenation Res, 2011. PMID 20822369
2011 / Intervention study
Older adults (mean age 74.7±6.9 years) were administered a high versus low nitrate diet to determine effects on cerebral blood flow. Cerebral perfusion was measured using arterial spin labeling magnetic resonance imaging. The high-nitrate diet did not alter global cerebral perfusion, but did increase regional cerebral perfusion in frontal lobe white matter, specifically between the dorsolateral prefrontal cortex and anterior cingulate cortex.
Presley TD, Morgan AR, Bechtold E, et al. Nitric Oxide, 2011. PMID 20951824
2011 / Before-and-after pilot study
Nine healthy men underwent dynamic susceptibility contrast-enhanced MRI before and after receiving 60 mg of Ginkgo biloba extract twice daily for 4 weeks. Individual lobar regions showed no significant CBF changes, but voxel-based mapping showed a small CBF increase in the left parietal-occipital region (P <= 0.001). Combining all regions revealed a significant increase in non-normalized CBF after supplementation (15% in white matter and 13% in gray matter, P <= 0.0001).
Mashayekh A, Pham DL, Yousem DM, et al. Neuroradiology, 2011. PMID 21061003
2011 / Randomized controlled trial
In a randomized, double-blind, placebo-controlled trial, 150 healthy adults aged 65 to 70 received either 13.7 g/day of a goji berry formulation (n = 75) or placebo (n = 75) for 90 days. The placebo group showed macular hypopigmentation and soft drusen accumulation, whereas the supplemented group remained stable. Goji berry supplementation also increased plasma zeaxanthin by 26% and antioxidant capacity by 57%, with no product-related adverse events.
Bucheli P, Vidal K, Shen L, et al. Optom Vis Sci, 2011. PMID 21169874
2011 / Multicenter, randomized, double-blind, placebo-controlled trial
A 24-month trial evaluated the safety and clinical outcomes of daily supplementation with 80 or 120 mg aglycone equivalent soy hypocotyl isoflavones (plus calcium and vitamin D) versus placebo in 403 postmenopausal women. After 2 years, all clinical chemistry values remained within normal ranges, though blood urea nitrogen increased significantly at 2 years (P = 0.048) but not at 1 year (P = 0.343). Isoflavone supplementation did not alter blood lymphocyte or serum free thyroxine concentrations, nor did it cause significant differences in endometrial thickness or fibroids. Two serious adverse events occurred (one breast cancer and one estrogen receptor-negative endometrial cancer), which was below the expected population rate.
Steinberg FM, Murray MJ, Lewis RD, et al. Am J Clin Nutr, 2011. PMID 21177797
2011 / Randomized controlled trial
A randomized controlled trial examined whether aerobic exercise training modifies hippocampal volume in 120 older adults. Exercise training increased hippocampal volume by 2%, effectively reversing age-related loss by 1 to 2 years, and led to improvements in spatial memory. Increased hippocampal volume was associated with higher serum BDNF levels, whereas hippocampal volume declined in the control group. Caudate nucleus and thalamus volumes remained unaffected by the intervention.
Erickson KI, Voss MW, Prakash RS, et al. Proc Natl Acad Sci U S A, 2011. PMID 21282661
2011 / Open-label clinical pilot study
In an open-label pilot study, 14 participants with pain-associated range of motion limitations consumed 120 mL of an açai-fortified fruit and berry juice blend daily for 12 weeks. Juice consumption resulted in significant pain reduction, improved range of motion measures, and improvement in activities of daily living. Serum antioxidant status improved within 2 weeks and continued through 12 weeks (P < .01), while reductions in C-reactive protein did not reach statistical significance and lipid peroxidation decreased mildly.
Jensen GS, Ager DM, Redman KA, et al. J Med Food, 2011. PMID 21470042
2011 / Cluster randomized factorial trial
Older adults in Chile were randomized by health center to receive a daily micronutrient-rich nutritional supplement, two 1-hour physical activity classes weekly, both, or neither for 24 months. Over 24 months, pneumonia incidence did not differ between intervention and control clusters (32.5 vs. 32.6 per 1,000 person-years; RR 1.00; 95% CI 0.61–1.63; p=0.99). However, physical activity intervention clusters achieved a significantly higher walking capacity after 24 months compared to controls (mean difference 33.8 meters; 95% CI 13.9–53.8; p=0.001). Adherence was approximately 75% for the supplement and 43% for physical activity, with no serious adverse events reported.
Dangour AD, Albala C, Allen E, et al. PLoS Med, 2011. PMID 21526229
2011 / Pilot comparative study
In a 4-week pilot study, researchers evaluated the effect of a plant-food menu (PFD) compared to an omnivorous menu on motor performance in 25 Parkinson's disease patients (12 in the intervention group [PDi] and 13 in the control group [PDc]). After 4 weeks, the PDi group showed significant reductions compared to controls in the Unified Parkinson's Disease Rating Scale total score (47.67 vs. 74.46, P = 0.008), sub-score III motor performances (25.42 vs. 46.46, P = 0.001), and the modified Hoehn and Yahr Staging Scale (1.96 vs. 3.15, P = 0.005). These data suggest that PFD may be useful in improving motor performances in Parkinson's disease, though additional studies are needed to confirm these preliminary results.
Baroni L, Bonetto C, Tessan F, et al. Nutr Neurosci, 2011. PMID 21535916
2011 / Randomized controlled trial
In a randomized trial, 160 osteopenic postmenopausal women were assigned to receive either 100 g/day of dried plum or dried apple as a comparative control for 12 months, with all participants receiving daily calcium (500 mg) and vitamin D (400 IU). Dried plum significantly increased the BMD of the ulna and spine compared with dried apple. Additionally, only the dried plum group showed significant decreases from baseline in serum bone turnover markers, including bone-specific alkaline phosphatase and tartrate-resistant acid phosphatase-5b.
Hooshmand S, Chai SC, Saadat RL, et al. Br J Nutr, 2011. PMID 21736808
2010 / Randomized controlled trial
In a 22-week randomized trial involving 54 community-dwelling adults aged 55 or older with mild-to-moderate Alzheimer's disease, 30 mg daily of saffron showed similar efficacy to 10 mg daily of donepezil. Cognitive subscale and clinical dementia rating scores were the primary outcomes. Overall adverse events occurred at similar rates, although vomiting was significantly more frequent in participants receiving donepezil.
Akhondzadeh S, Shafiee Sabet M, Harirchian MH, et al. Psychopharmacology (Berl), 2010. PMID 19838862
2010 / Randomized controlled trial
In a randomized, double-blind, placebo-controlled trial, 12 older adults with early memory decline consumed Concord grape juice or placebo for 12 weeks. Grape juice supplementation significantly improved verbal learning, with non-significant enhancements in verbal and spatial recall. No effects were observed on depressive symptoms, body weight, or waist circumference, though fasting insulin increased slightly.
Krikorian R, Nash TA, Shidler MD, et al. Br J Nutr, 2010. PMID 20028599
2010 / Intervention trial with companion matched control comparison
This study investigated the effects of daily consumption of wild blueberry juice in nine older adults with early memory changes over 12 weeks. Participants demonstrated improved paired associate learning (p = 0.009) and word list recall (p = 0.04), alongside trends toward reduced depressive symptoms (p = 0.08) and lower glucose levels (p = 0.10). When compared with a demographically matched sample consuming a placebo berry beverage in a companion trial, comparable results were seen for paired associate learning.
Krikorian R, Shidler MD, Nash TA, et al. J Agric Food Chem, 2010. PMID 20047325
2010 / Controlled clinical trial
In a controlled study, 16 individuals with type 2 diabetes and 21 matched controls aged 50 to 75 participated in a six-week exercise regimen. Prior to training, diabetic subjects showed higher falls risk, slower reaction speeds, and greater sway. After the balance and resistance intervention, the diabetic cohort demonstrated increased leg strength, quicker reactions, diminished postural sway, and lower falls risk scores.
Morrison S, Colberg SR, Mariano M, et al. Diabetes Care, 2010. PMID 20097781
2010 / Open-label clinical trial
In an open-label pilot study, 21 institutionalized individuals with moderate-to-severe Alzheimer's disease consumed two 4-oz glasses of apple juice daily for 1 month. Participants showed no change in the Dementia Rating Scale or ADCS-Activities of Daily Living. However, caregivers reported an approximate 27% (P < .01) improvement in behavioral and psychotic symptoms on the Neuropsychiatric Inventory, with the largest changes observed in anxiety, agitation, and delusion.
Remington R, Chan A, Lepore A, et al. Am J Alzheimers Dis Other Demen, 2010. PMID 20338990
2010 / Randomized crossover trial
A randomized, double-blind crossover pilot trial evaluated 2 weeks of a tart cherry juice blend versus placebo in 15 older adults with chronic insomnia. Tart cherry juice significantly decreased minutes awake after sleep onset compared with placebo. However, it did not significantly improve sleep latency, total sleep time, or sleep efficiency relative to placebo, with overall effect sizes characterized as moderate to negligible.
Pigeon WR, Carr M, Gorman C, et al. J Med Food, 2010. PMID 20438325
2010 / Randomised single-blind acute cross-over trial
A randomized single-blind acute crossover study evaluated calcium absorption from soymilk fortified with a proprietary phosphate of calcium compared with cow's milk in 12 osteopenic post-menopausal women. Participants consumed 20 mL of test milk labeled with 185 kBq of 45Ca in 44 mg of calcium carrier to determine the hourly fractional calcium absorption rate (alpha). The mean hourly fractional calcium absorption from fortified soymilk was comparable to that of cow's milk (alpha = 0.65 +/- 0.19 vs. alpha = 0.66 +/- 0.22, p > 0.05).
Tang AL, Walker KZ, Wilcox G, et al. Asia Pac J Clin Nutr, 2010. PMID 20460239
2010 / Randomized controlled trial
A randomized trial assigned 2,256 community-dwelling women aged 70 years or older at high fracture risk to an annual dose of 500,000 IU cholecalciferol or placebo for 3 to 5 years. The vitamin D group experienced more fractures (171 vs 135; incidence RR 1.26, 95% CI 1.00-1.59, P = 0.047) and more falls (incidence RR 1.15, 95% CI 1.02-1.30, P = 0.03).
Sanders KM, Stuart AL, Williamson EJ, et al. JAMA, 2010. PMID 20460620
2010 / Randomized trial
Thirty healthy women over 50 were randomized to receive either 30 mg/day or 90 mg/day of dietary beta-carotene for 90 days. Facial wrinkles and elasticity improved significantly only in the 30 mg/day group, where type I procollagen mRNA levels increased to 4.4 +/- 1.6 times baseline along with decreased UV-induced thymine dimer and 8-hydroxy-2'-deoxyguanosine staining. In contrast, minimal erythema dose decreased significantly in the high-dose group, and UV-induced thymine dimer staining tended to increase.
Cho S, Lee DH, Won CH, et al. Dermatology, 2010. PMID 20516658
2010 / Clinical trial
Researchers evaluated the effect of consuming seven different Jerte Valley cherry cultivars on the sleep-wake cycle, 6-sulfatoxymelatonin levels, and urinary total antioxidant capacity in middle-aged and elderly participants. Nocturnal activity and rest were measured by actigraphic monitoring. Intake of each cherry cultivar led to beneficial effects on actual sleep time, total nocturnal activity, assumed sleep, and immobility. Significant increases in urinary 6-sulfatoxymelatonin levels and total antioxidant capacity were also observed after intake of each cultivar.
Garrido M, Paredes SD, Cubero J, et al. J Gerontol A Biol Sci Med Sci, 2010. PMID 20547498